Mattia Galli/LinkedIn
Dec 19, 2025, 12:07
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, posted on LinkedIn:
”Can we drop oral anticoagulant therapy after successful atrial fibrillation ablation?”
Read the full article here.
Title: OCEAN trial: rethinking long-term anticoagulation after atrial fibrillation ablation
Authors: Mattia Galli, Beatrice Simeone, Sebastiano Sciarretta
Stay updated with Hemostasis Today.
Anticoagulation
Atrial Fibrillation
Atrial Fibrillation Ablation
Beatrice Simeone
Cardiology
ESC
European Heart Journal
European Society of Cardiology
Health
Heart Health
Hematology
Hemostasis
Hemostasis Today
Long-term Anticoagulation
Mattia Galli
Medicine
OCEAN Trial
Sapienza University of Rome
Sebastiano Sciarretta
thrombosis
-
Sep 8, 2026, 16:14Heghine Khachatryan: Colombo 2026 Insights on Point-of-Care Ultrasound in Hemophilia Joint Care
-
Sep 8, 2026, 15:57Flora Peyvandi: Efficiency Meets Innovation in Hemophilia B Gene Therapy
-
Sep 8, 2026, 15:48Maxime Dely: Guillain-Barré Syndrome – What if the Key Lies in the Plasma?
-
Sep 8, 2026, 15:34Ron DePinho: A Negative Trial Highlights the Need for Precision in Cardiovascular Inflammation
-
Sep 8, 2026, 15:31Adil Yousaf: Thrombolysis Speed Matters, but Eligibility Comes First
-
Sep 8, 2026, 15:28Dhargam Aljebouri: First Molecularly Characterized Para-Bombay Phenotype in the Arab World
-
Sep 8, 2026, 15:27Mohd Ashhad: How Much Does Hemoglobin Increase After 1 Unit of PRBC?
-
Sep 8, 2026, 15:27Sanish Babu: The Hematocrit–Platelet Signal in Severe Dengue
-
Sep 8, 2026, 15:26Mary Kama: Climate-Informed Early Warning Systems for Sickle Cell Anaemia